APA (7th ed.) Citation

S, P., E, P., V, Q., J, M., A, L., G, G., . . . A, G. (2022). Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer, 128(1), 85. https://doi.org/10.1002/cncr.33895

Chicago Style (17th ed.) Citation

S, Pasquali, et al. "Neoadjuvant Chemotherapy in High-risk Soft Tissue Sarcomas: A Sarculator-based Risk Stratification Analysis of the ISG-STS 1001 Randomized Trial." Cancer 128, no. 1 (2022): 85. https://doi.org/10.1002/cncr.33895.

MLA (9th ed.) Citation

S, Pasquali, et al. "Neoadjuvant Chemotherapy in High-risk Soft Tissue Sarcomas: A Sarculator-based Risk Stratification Analysis of the ISG-STS 1001 Randomized Trial." Cancer, vol. 128, no. 1, 2022, p. 85, https://doi.org/10.1002/cncr.33895.